Abstract
The prevalence of cardiometabolic risk factors (CMRFs) is increasing in sub-Saharan Africa and represents a serious health issue. Specific and accurate data are required to implement prevention programs and healthcare strategies. Thus, the aim of this study was to estimate the prevalence rates of CMRFs according to the level of urbanization, age and gender in Gabon.
A cross-sectional study was conducted using the World Health Organization’s (WHO) stepwise approach for the surveillance of chronic disease risk factors. Participants over 18 years of age, without known underlying disease, from rural and urban areas of Gabon were included. Biological and behavioral data were collected using an adapted version of the standardized WHO survey questionnaire.
The median age was 38[28–50] years. Tobacco consumption was more frequent in rural areas than in urban areas (26.1% vs 6.2%; p < 0.01). Men were more likely to be smokers than women, in both settings (aOR: 8.0[4.9-13.5], p < 0.01). Excessive alcohol consumption (19.4% vs 9.6%; p < 0.01) predominated in rural than in urban areas. Urban dwellers were less physically active than rural people (29.5% vs 16.3%; p < 0.01). In total, 79.9% of participants aged under 54 years had a high blood pressure (HBP) while 10.6% of the younger participants had pre-hypertension. Metabolic syndrome was higher in women (21.7% vs 10.0%; p < 0.01) than in men. Furthermore, 6.4% of men and 2.5% of women had a high risk of developing coronary heart diseases in the next 10 years (p = 0.03). Finally, 54.0% of the study population had three or four risk factors.
The prevalence rates of CMRFs were high in the study population. Disparities were observed according to urban and rural areas, gender and age groups. National prevention and healthcare strategies for cardiometabolic diseases in Gabon should take into account these observed differences.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
None
Funding Statement
This study is part of the Parcam (TMA2017-1956CSF) project funded by the EDCTP2 program to Marielle Karine Bouyou Akotet.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ministry of Health of Gabon and the National Ethical Committee under the reference (PROT N° 002/2020/PR/SG/CNE). Each participant was informed on the study procedures and consented to participate in the study by signing an informed consent form. Participants benefited from free biological tests.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data will be sent on demand
None
